These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22322898)
1. Drug release patterns and cytotoxicity of PEG-poly(aspartate) block copolymer micelles in cancer cells. Eckman AM; Tsakalozou E; Kang NY; Ponta A; Bae Y Pharm Res; 2012 Jul; 29(7):1755-67. PubMed ID: 22322898 [TBL] [Abstract][Full Text] [Related]
2. Block copolymer micelles with acid-labile ortho ester side-chains: Synthesis, characterization, and enhanced drug delivery to human glioma cells. Tang R; Ji W; Panus D; Palumbo RN; Wang C J Control Release; 2011 Apr; 151(1):18-27. PubMed ID: 21194551 [TBL] [Abstract][Full Text] [Related]
3. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake. Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug release. Lee HJ; Bae Y Pharm Res; 2013 Feb; 30(2):478-88. PubMed ID: 23054094 [TBL] [Abstract][Full Text] [Related]
5. Nanomicelle drug with acid-triggered doxorubicin release and enhanced cellular uptake ability based on mPEG-graft-poly(N-(2-aminoethyl)-L-aspartamide)-hexahydrophthalic acid copolymers. Cao L; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J J Biomater Appl; 2018 Jan; 32(6):826-838. PubMed ID: 29132238 [TBL] [Abstract][Full Text] [Related]
6. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818 [TBL] [Abstract][Full Text] [Related]
8. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release. Cunningham AJ; Robinson M; Banquy X; Leblond J; Zhu XX Mol Pharm; 2018 Mar; 15(3):1266-1276. PubMed ID: 29378128 [TBL] [Abstract][Full Text] [Related]
9. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery. Rongbin H; Lei X; Ying L; Xiangping D; Xuan C; Lanfang L; Cuiyun Y; Yanming C; Guotao T J Pharm Pharmacol; 2016 Jun; 68(6):751-61. PubMed ID: 27018539 [TBL] [Abstract][Full Text] [Related]
11. Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles. Ponta A; Bae Y J Drug Target; 2014 Aug; 22(7):619-28. PubMed ID: 24766185 [TBL] [Abstract][Full Text] [Related]
12. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612 [TBL] [Abstract][Full Text] [Related]
13. Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice. Wei X; Wang Y; Zeng W; Huang F; Qin L; Zhang C; Liang W Pharm Res; 2012 Jul; 29(7):1977-89. PubMed ID: 22426964 [TBL] [Abstract][Full Text] [Related]
14. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Xu W; Siddiqui IA; Nihal M; Pilla S; Rosenthal K; Mukhtar H; Gong S Biomaterials; 2013 Jul; 34(21):5244-53. PubMed ID: 23582862 [TBL] [Abstract][Full Text] [Related]
15. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery. Mahmud A; Xiong XB; Lavasanifar A Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550 [TBL] [Abstract][Full Text] [Related]
16. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022 [TBL] [Abstract][Full Text] [Related]
17. Preparation of polyethylene glycol-polyacrylic acid block copolymer micelles with pH/hypoxic dual-responsive for tumor chemoradiotherapy. Weng J; Huang Z; Pu X; Chen X; Yin G; Tian Y; Song Y Colloids Surf B Biointerfaces; 2020 Jul; 191():110943. PubMed ID: 32203861 [TBL] [Abstract][Full Text] [Related]
18. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559 [TBL] [Abstract][Full Text] [Related]
19. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release. Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711 [TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy. Gao D; Lo PC J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]